TrialsgrambetaRCTs are beautiful
ESC Congress 2026Presented Mon 31 Aug · 13:45 CESTHot Line 11All Hot Line trials →

CoCAP

2026

Coronary CT Angio Evaluating Graft Patency in ACS Patients Treated With DAPT or Single ASA After CABG (CoCAP)

In 360 patients after CABG for an acute coronary syndrome, dual antiplatelet therapy with ticagrelor was compared with aspirin alone on graft patency on CT angiography at 12–36 months.

Result

Graft patency on CCTA (FitzGibbon grade A) at 12–36 months, without previous graft failure identified on CCTA or invasive angiography since CABG
Absolute difference
1.7 points
Effect estimate

adjusted risk difference1.295% CI -4.7 to 7.0 · P = 0.70

The absolute difference is derived from the event rates.

Also reported: Patient-level graft patency (<50 % stenosis) in 368 analysed. Non-occlusion 87.6 % vs 85.5 % (adjusted difference 2.1 %; P = 0.42), with no consistent interaction across prespecified subgroups. Imaging at a single timepoint with selection bias and incomplete adherence; the parent TACSI trial was neutral for MACE with more bleeding on DAPT. UNVERIFIED: figures read off a third-party congress summary, not yet checked against a primary source.

Subtopic
Antiplatelet after CABG
Design
Prospective observational coronary CT angiography substudy nested in the registry-based randomised TACSI trial (1:1 dual antiplatelet therapy with aspirin plus ticagrelor versus aspirin alone for 12 months after isolated CABG for ACS); CCTA performed 12–36 months after CABG; intention-to-treat by TACSI allocation; sites in Sweden and Norway
Source
Holm J, et al. CoCAP: Coronary CT angiography evaluating graft patency in ACS patients treated with DAPT or single ASA after CABG. Presented at ESC Congress 2026, Hot Line 11, 31 August 2026, Munich. ClinicalTrials.gov NCT04783701. No primary publication indexed as of 1 September 2026.